PPD Said to Seek $2.2 Billion of Leveraged Buyout Financing
This article is for subscribers only.
Pharmaceutical Product Development Inc. plans to finance its buyout by Carlyle Group and Hellman & Friedman LLC with $2.2 billion of debt, according to a person with knowledge of the matter.
The company is seeking a $1.33 billion first-lien term loan, a $175 million revolving credit line and $700 million of bridge financing, said the person, who declined to be identified because the deal is private.